Fortitude Advisory Group’s NEVRO CORP. NVRO Stock Holding History

Fortitude Advisory Group’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-100	Closed	-$7K	–	1364
2022 Q1	$7K	Hold	100	–	–	﹤0.01%	1117
2021 Q4	$8K	Buy	+100	New	+$10K	﹤0.01%	1109

Other funds holding NVRO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fortitude Advisory Group's NVRO Position: Q2 2022 in Review

Fortitude Advisory Group sold out of NEVRO CORP. (NVRO) in Q2 2022, closing a stake of 100 shares — an estimated $7K sold.

Fortitude Advisory Group first reported a position in NVRO in Q4 2021 and held it in 2 quarters. The position peaked at $8K in Q4 2021. 176 funds tracked by Wall St. Rank hold NVRO as of Q2 2022.

Fortitude Advisory Group reported no remaining NEVRO CORP. position as of Q2 2022 after selling out during the quarter.
Fortitude Advisory Group sold 100 NEVRO CORP. shares in Q2 2022, an estimated $7K.
Fortitude Advisory Group first reported a position in NEVRO CORP. in Q4 2021 and held it in 2 quarters.
Fortitude Advisory Group's NEVRO CORP. position peaked at $8K in Q4 2021.
176 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2022.

Based on Fortitude Advisory Group's 13F filing for Q2 2022, filed 16 Aug 2022.